|
US3657744A
(en)
|
1970-05-08 |
1972-04-25 |
Univ Minnesota |
Method for fixing prosthetic implants in a living body
|
|
US4733665C2
(en)
|
1985-11-07 |
2002-01-29 |
Expandable Grafts Partnership |
Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
JPS62135835A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62135832A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62135834A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62135830A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料及びその処理方法
|
|
JPS62136651A
(ja)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料の処理方法
|
|
JPS62136654A
(ja)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JPS62136650A
(ja)
|
1985-12-11 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料及びその処理方法
|
|
US5350395A
(en)
|
1986-04-15 |
1994-09-27 |
Yock Paul G |
Angioplasty apparatus facilitating rapid exchanges
|
|
US5061273A
(en)
|
1989-06-01 |
1991-10-29 |
Yock Paul G |
Angioplasty apparatus facilitating rapid exchanges
|
|
US5040548A
(en)
|
1989-06-01 |
1991-08-20 |
Yock Paul G |
Angioplasty mehtod
|
|
US4748982A
(en)
|
1987-01-06 |
1988-06-07 |
Advanced Cardiovascular Systems, Inc. |
Reinforced balloon dilatation catheter with slitted exchange sleeve and method
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
GB8808433D0
(en)
|
1988-04-11 |
1988-05-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA1322628C
(en)
|
1988-10-04 |
1993-10-05 |
Richard A. Schatz |
Expandable intraluminal graft
|
|
US5292331A
(en)
|
1989-08-24 |
1994-03-08 |
Applied Vascular Engineering, Inc. |
Endovascular support device
|
|
US5674278A
(en)
|
1989-08-24 |
1997-10-07 |
Arterial Vascular Engineering, Inc. |
Endovascular support device
|
|
US6344053B1
(en)
|
1993-12-22 |
2002-02-05 |
Medtronic Ave, Inc. |
Endovascular support device and method
|
|
US5041453A
(en)
|
1990-05-30 |
1991-08-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4
|
|
US6063930A
(en)
|
1996-04-03 |
2000-05-16 |
Merck & Co., Inc. |
Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
|
|
WO1997036876A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
IL135900A0
(en)
|
1997-11-04 |
2001-05-20 |
Pfizer Prod Inc |
Indazole bioisostere replacement of catechol in therapeuticaly active compounds
|
|
IL135714A0
(en)
|
1997-11-04 |
2001-05-20 |
Pfizer Prod Inc |
Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
|
|
GB9908934D0
(en)
|
1999-04-19 |
1999-06-16 |
Rolic Ag |
Liquid crystalline compounds
|
|
EP1046631A1
(en)
|
1999-04-19 |
2000-10-25 |
Rolic AG |
Liquid crystalline compounds
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
CN1300116C
(zh)
|
2001-04-16 |
2007-02-14 |
卫材株式会社 |
1h－吲唑化合物
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
US7429609B2
(en)
|
2002-05-31 |
2008-09-30 |
Eisai R & D Management Co., Ltd. |
Pyrazole compound and medicinal composition containing the same
|
|
EP1545515A1
(en)
|
2002-08-12 |
2005-06-29 |
Sugen, Inc. |
3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
|
|
WO2004110350A2
(en)
|
2003-05-14 |
2004-12-23 |
Torreypines Therapeutics, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
|
CA2542220A1
(en)
|
2003-10-22 |
2005-05-06 |
Eli Lilly And Company |
Novel mch receptor antagonists
|
|
WO2005060958A1
(en)
|
2003-12-19 |
2005-07-07 |
Kalypsys, Inc. |
(5- (2-phenyl)-thiazol-5-ylmethoxy)-indol-1-yl) -acetic acid derivatives and related compounds as modulators of the human ppar-delta receptor for the treatment of metabolic disorders such as type 2 diabetes
|
|
WO2006071875A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
WO2006071958A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
WO2006096564A1
(en)
|
2005-03-04 |
2006-09-14 |
Merck & Co., Inc. |
Fused aromatic compounds having anti-diabetic activity
|
|
WO2007050124A1
(en)
|
2005-05-19 |
2007-05-03 |
Xenon Pharmaceuticals Inc. |
Fused piperidine derivatives and their uses as therapeutic agents
|
|
WO2007044085A2
(en)
|
2005-05-19 |
2007-04-19 |
Xenon Pharmaceuticals Inc. |
Heteroaryl compounds and their uses as therapeutic agents
|
|
WO2007058626A1
(en)
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
|
CA2644910C
(en)
|
2006-03-31 |
2014-01-28 |
Abbott Laboratories |
Indazole compounds
|
|
DE102006030479A1
(de)
|
2006-07-01 |
2008-03-20 |
Merck Patent Gmbh |
Indazolderivate
|
|
WO2008008650A1
(en)
|
2006-07-10 |
2008-01-17 |
Indiana University Research And Technology Corporation |
Methods for treating cystic kidney diseases
|
|
SG177225A1
(en)
|
2006-12-01 |
2012-01-30 |
Agency Science Tech & Res |
Cancer-related protein kinases
|
|
MX2009008439A
(es)
|
2007-02-12 |
2009-08-13 |
Intermune Inc |
Nuevos inhibidores de la replicacion del virus de hepatitis c.
|
|
JP5330375B2
(ja)
|
2007-04-25 |
2013-10-30 |
エグゼリクシス， インコーポレイテッド |
カゼインキナーゼｉｉ（ｃｋ２）モジュレーターとしてのピリミジノン類
|
|
AU2008248186B2
(en)
|
2007-05-07 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Method of treatment using fused aromatic compounds having anti-diabetic activity
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
JP2010111624A
(ja)
|
2008-11-06 |
2010-05-20 |
Shionogi & Co Ltd |
Ｔｔｋ阻害作用を有するインダゾール誘導体
|
|
CA2750577A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
EP2379563B1
(en)
|
2008-12-22 |
2014-07-16 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
WO2010088518A2
(en)
|
2009-01-31 |
2010-08-05 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
|
US20120040977A1
(en)
|
2009-02-23 |
2012-02-16 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
US8455516B2
(en)
|
2010-01-15 |
2013-06-04 |
Touro University |
HIV-1 fusion inhibitors and methods
|
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
|
EP2368876A1
(en)
|
2010-03-01 |
2011-09-28 |
Sanofi |
Derivatives of aminoindanes, their preparation and their application in therapeutics
|
|
US20130079348A1
(en)
|
2010-03-03 |
2013-03-28 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
JP5763937B2
(ja)
|
2010-03-10 |
2015-08-12 |
Ａｇｃセイミケミカル株式会社 |
液晶化合物、その製造方法、液晶組成物および液晶電気光学素子
|
|
WO2011143365A1
(en)
|
2010-05-13 |
2011-11-17 |
Amgen Inc. |
Nitrogen heterocyclic compounds useful as pde10 inhibitors
|
|
PE20130774A1
(es)
|
2010-07-29 |
2013-06-26 |
Rigel Pharmaceuticals Inc |
Compuestos heterociclicos activadores de ampk y metodos para emplearlos
|
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
|
US20130310379A1
(en)
|
2010-11-19 |
2013-11-21 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2012092471A2
(en)
|
2010-12-29 |
2012-07-05 |
Development Center For Biotechnology |
Novel tubulin inhibitors and methods of using the same
|
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
SG194625A1
(en)
|
2011-05-23 |
2013-12-30 |
Sanofi Sa |
Process for the preparation of deuterated compounds containing n-alkyl groups
|
|
CN102243505B
(zh)
|
2011-07-07 |
2013-08-14 |
矽力杰半导体技术(杭州)有限公司 |
一种低失调、快速响应的电压控制电流源、控制方法以及应用其的电源电路
|
|
US9267176B2
(en)
|
2011-08-05 |
2016-02-23 |
Astellas Pharma Inc. |
Method for detecting novel FGFR4 mutant
|
|
JP2014525932A
(ja)
|
2011-08-15 |
2014-10-02 |
インターミューン， インコーポレイテッド |
リゾホスファチド酸レセプターアンタゴニスト
|
|
JP6096778B2
(ja)
|
2011-09-01 |
2017-03-15 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ピロロピラジンキナーゼ阻害剤
|
|
CN108484449A
(zh)
|
2011-09-09 |
2018-09-04 |
蓝瑟斯医学影像公司 |
用于合成和使用显像剂的组合物、方法和系统
|
|
GB201118656D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
US9254288B2
(en)
|
2012-05-07 |
2016-02-09 |
The Translational Genomics Research Institute |
Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof
|
|
CN103420906B
(zh)
|
2012-05-21 |
2015-09-09 |
南京圣和药业股份有限公司 |
新型酪氨酸蛋白激酶抑制剂
|
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
|
US11230589B2
(en)
|
2012-11-05 |
2022-01-25 |
Foundation Medicine, Inc. |
Fusion molecules and uses thereof
|
|
US20140213538A1
(en)
|
2013-01-15 |
2014-07-31 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
|
CA3150658A1
(en)
|
2013-01-18 |
2014-07-24 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
|
KR101648141B1
(ko)
|
2013-06-11 |
2016-08-12 |
제일모직 주식회사 |
화합물, 이를 포함하는 유기 광전자 소자 및 상기 유기 광전자 소자를 포함하는 표시장치
|
|
US10124003B2
(en)
|
2013-07-18 |
2018-11-13 |
Taiho Pharmaceutical Co., Ltd. |
Therapeutic agent for FGFR inhibitor-resistant cancer
|
|
WO2015035415A1
(en)
|
2013-09-09 |
2015-03-12 |
Nantomics, Llc |
Method of detecting suceptibility to breast cancer through mutations in the fgfr3 and tp53 genes
|
|
US20150087673A1
(en)
|
2013-09-26 |
2015-03-26 |
Rigel Pharmaceuticals, Inc. |
Methods for using and biomarkers for ampk-activating compounds
|
|
US9546162B2
(en)
|
2013-09-27 |
2017-01-17 |
Allergan, Inc. |
Compounds and methods for skin repair
|
|
US9931347B2
(en)
|
2013-12-03 |
2018-04-03 |
Iomet Pharma Ltd. |
Pharmaceutical compound
|
|
US10767222B2
(en)
|
2013-12-11 |
2020-09-08 |
Accuragen Holdings Limited |
Compositions and methods for detecting rare sequence variants
|
|
JP6514645B2
(ja)
|
2013-12-27 |
2019-05-15 |
中外製薬株式会社 |
Ｆｇｆｒゲートキーパー変異遺伝子およびそれを標的とする医薬
|
|
WO2015103527A1
(en)
|
2014-01-06 |
2015-07-09 |
The Scripps Research Institute |
Modulators of rev-erb
|
|
US20160340742A1
(en)
|
2014-02-04 |
2016-11-24 |
Mayo Foundation For Medical Education And Research |
Method of Identifying Tyrosine Kinase Receptor Rearrangements in Patients
|
|
CN106459993A
(zh)
|
2014-03-31 |
2017-02-22 |
德彪药业国际股份公司 |
Fgfr融合体
|
|
WO2015154169A1
(en)
|
2014-04-09 |
2015-10-15 |
The University Of British Columbia |
Binding function3 (bf3) site compounds as therapeutics and methods for their use
|
|
KR102352667B1
(ko)
|
2014-05-09 |
2022-01-19 |
메르크 파텐트 게엠베하 |
액정 매질 및 이를 포함하는 고주파 부품
|
|
CA2949511A1
(en)
|
2014-05-19 |
2015-11-26 |
Merial, Inc. |
Anthelmintic compounds
|
|
WO2016022446A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[5,6]-fused bicyclic antidiabetic compounds
|
|
US20170281642A1
(en)
|
2014-08-28 |
2017-10-05 |
Oncoethix Gmbh |
Methods of treating acute myeloid leukemia or acute lymphoid leukemia using pharmaceutical compositions containing thienotriazolodiazepine compounds
|
|
JP2017535646A
(ja)
|
2014-11-11 |
2017-11-30 |
メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ ＧｍｂＨ |
ビメソゲン化合物及びメソゲン媒体
|
|
JP2018027019A
(ja)
|
2014-11-26 |
2018-02-22 |
国立研究開発法人国立がん研究センター |
胆道がんにおける新規治療標的融合遺伝子
|
|
WO2016105503A1
(en)
|
2014-12-24 |
2016-06-30 |
Genentech, Inc. |
Therapeutic, diagnostic and prognostic methods for cancer of the bladder
|
|
EP3265462A1
(en)
|
2015-03-03 |
2018-01-10 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Fgfr3 antagonists
|
|
KR101663277B1
(ko)
|
2015-03-30 |
2016-10-06 |
주식회사 녹십자 |
TNIK, IKKε 및 TBK1 억제제로서의 피라졸계 유도체 및 이를 포함하는 약학적 조성물
|
|
WO2016172631A2
(en)
|
2015-04-24 |
2016-10-27 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
|
|
CN106317023A
(zh)
|
2015-07-10 |
2017-01-11 |
中国科学院上海药物研究所 |
吲唑类化合物的制备方法和用途
|
|
EP3333157B1
(en)
*
|
2015-08-07 |
2020-12-23 |
Harbin Zhenbao Pharmaceutical Co., Ltd. |
Vinyl compounds as fgfr and vegfr inhibitors
|
|
WO2017066705A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
WO2017068064A1
(en)
|
2015-10-22 |
2017-04-27 |
Selvita S.A. |
Pyridone derivatives and their use as kinase inhibitors
|
|
JPWO2017150586A1
(ja)
|
2016-03-02 |
2019-01-31 |
Jnc株式会社 |
積層体、電子機器、積層体の製造方法
|
|
JP6959488B2
(ja)
|
2016-03-02 |
2021-11-02 |
Jnc株式会社 |
低熱膨張部材用組成物、低熱膨張部材、電子機器、低熱膨張部材の製造方法
|
|
PL3429591T3
(pl)
|
2016-03-16 |
2023-07-17 |
Kura Oncology, Inc. |
Podstawione pochodne tieno[2,3-d]pirymidyny jako inhibitory meniny-mll i metody ich zastosowania
|
|
US20190177617A1
(en)
|
2016-05-12 |
2019-06-13 |
Merck Patent Gmbh |
Bimesogenic compounds and mesogenic media
|
|
US11124628B2
(en)
|
2016-08-30 |
2021-09-21 |
Dow Global Technologies Llc |
Method of attenuating concerntration of acrolein
|
|
JP6589795B2
(ja)
|
2016-09-27 |
2019-10-16 |
信越化学工業株式会社 |
スルホニウム塩、レジスト組成物及びパターン形成方法
|
|
WO2018226976A1
(en)
|
2017-06-08 |
2018-12-13 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
|
WO2019018795A1
(en)
|
2017-07-20 |
2019-01-24 |
Yumanity Therapeutics |
COMPOUNDS AND USES THEREOF
|
|
EP3669872A4
(en)
|
2017-08-18 |
2021-05-05 |
Shanghai Ennovabio Pharmaceuticals Co., Ltd. |
FORMYL PYRIDINE DERIVATIVE WITH PD-L1 INHIBITORING EFFECT, MANUFACTURING METHOD FOR IT AND USE THEREOF
|
|
US11795162B2
(en)
|
2017-08-18 |
2023-10-24 |
Saint Louis University |
Modulators of the estrogen-related receptor
|
|
WO2019209948A1
(en)
|
2018-04-25 |
2019-10-31 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
JP2021536458A
(ja)
|
2018-09-04 |
2021-12-27 |
マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. |
アリール炭化水素レセプター・アンタゴニスト及び使用方法
|
|
KR102127006B1
(ko)
|
2018-12-06 |
2020-06-25 |
한국생산기술연구원 |
피리미딘계 작용기 함유 단분자 화합물, 상기 화합물의 광가교물을 포함한 유기물층 및 이를 포함하는 유기전자소자
|
|
WO2020139748A1
(en)
|
2018-12-28 |
2020-07-02 |
Cedars-Sinai Medical Center |
Methods of treating inflammatory bowel diseases that target ripk2
|
|
CN111434655A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
溶血磷脂酸受体拮抗剂及其制备方法
|
|
IN201941011265A
(https=)
*
|
2019-03-22 |
2020-09-25 |
|
|
|
EP3971187B1
(en)
|
2019-05-14 |
2025-05-07 |
Shanghai Hansoh Biomedical Co., Ltd. |
Inhibitor containing bicyclic derivative, preparation method therefor and use thereof
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
CN112409331B
(zh)
|
2019-08-21 |
2024-02-20 |
上海翰森生物医药科技有限公司 |
杂环类衍生物抑制剂、其制备方法和应用
|
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
CA3157361A1
(en)
|
2019-10-14 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
CN112812014B
(zh)
|
2019-11-15 |
2024-05-10 |
石家庄诚志永华显示材料有限公司 |
化合物、液晶组合物、液晶显示器
|
|
TW202128670A
(zh)
|
2019-11-26 |
2021-08-01 |
大陸商上海翰森生物醫藥科技有限公司 |
含氮多環類衍生物抑制劑、其製備方法和應用
|
|
WO2021127333A1
(en)
|
2019-12-19 |
2021-06-24 |
Casma Therapeutics, Inc. |
Trpml modulators
|
|
US12441707B2
(en)
*
|
2019-12-30 |
2025-10-14 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
WO2021155253A1
(en)
|
2020-01-31 |
2021-08-05 |
Atomwise Inc. |
Anat inhibitors and methods of use thereof
|
|
CA3166358A1
(en)
|
2020-02-12 |
2021-08-19 |
Monali BANERJEE |
Small molecule sting antagonists
|
|
US20230148214A1
(en)
|
2020-03-06 |
2023-05-11 |
ESCAPE Bio, Inc. |
Indazoles and azaindazoles as lrrk2 inhibitors
|
|
US20230140941A1
(en)
|
2020-03-13 |
2023-05-11 |
University Of Maryland, Baltimore |
Non-atp/catalytic site p38 mitogen activated protein kinase inhibitors
|
|
BR112022022511A2
(pt)
|
2020-05-06 |
2022-12-13 |
Servier Lab |
Inibidores macrocíclicos de lrrk2 quinase
|
|
KR20230152654A
(ko)
|
2020-12-30 |
2023-11-03 |
타이라 바이오사이언시스, 인크. |
키나아제 억제제로서의 인다졸 화합물
|
|
BR112023017834A2
(pt)
|
2021-03-18 |
2023-10-03 |
Servier Lab |
Inibidores de lrrk2 cinase macrocíclicos
|
|
JP2024512501A
(ja)
|
2021-03-19 |
2024-03-19 |
アルヴィナス・オペレーションズ・インコーポレイテッド |
インダゾール系化合物及び関連使用方法
|
|
US20240316022A1
(en)
*
|
2021-06-30 |
2024-09-26 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
KR20240171138A
(ko)
|
2022-04-04 |
2024-12-06 |
브레닉 테라퓨틱스 인코포레이티드 |
Lrrk2 저해제
|
|
TW202408493A
(zh)
|
2022-06-29 |
2024-03-01 |
美商泰拉生物科學公司 |
多晶形化合物及其用途
|
|
IL317558A
(en)
|
2022-06-29 |
2025-02-01 |
Tyra Biosciences Inc |
Indazole compounds
|
|
AU2023334178A1
(en)
|
2022-08-30 |
2025-03-13 |
Tyra Biosciences, Inc. |
Methods of treating solid tumors having activating fgfr3 gene alterations
|